| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 3 | |
| #2 | Canada | 3 | |
| #3 | EPO (European Patent Office) | 3 | |
| #4 | United States | 3 | |
| #5 | Brazil | 2 | |
| #6 | Israel | 2 | |
| #7 | China | 1 | |
| #8 | Hong Kong | 1 | |
| #9 | South Africa | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Measurement | |
| #4 | Environmental technology |
| # | Name | Total Patents |
|---|---|---|
| #1 | Weingarten M David | 9 |
| #2 | Meng Charles Q | 5 |
| #3 | Ng Raymond | 5 |
| #4 | Ni Liming | 4 |
| #5 | Ye Zhihong | 4 |
| #6 | Sikorski Jim A | 4 |
| #7 | Sikorski James A | 3 |
| #8 | Scott Robert A D | 3 |
| #9 | Borow Kenneth M | 3 |
| #10 | Maibach Hilda | 2 |
| Publication | Filing date | Title |
|---|---|---|
| CN102257389A | Screening method for identifying patients at risk of adverse hepatologic events | |
| AU2008251836A1 | Spiro compounds for treatment of inflammatory disorders | |
| US2009270454A1 | Sulfonamide containing compounds for treatment of inflammatory disorders | |
| BRPI0809423A2 | Uses and compositions of probucol derivatives for treatment of diabetes |